Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf7m1Btlr mutation
(1 available);
any
Irf7 mutation
(23 available)
|
|
|
immune system
|
• non-secretion of type I interferons (IFN-alpha/IFN-beta) by plasmacytoid dendritic cells (pDCs) in response to in vivo stimulation by the toll-like receptor 9 (TLR9) ligand, CpG
• reduced secretion of type I interferons (IFN-alpha/IFN-beta) by plasmacytoid dendritic cells in response to in vivo stimulation by resiquimod, a single-stranded (ss) RNA mimetic recognized by toll-like receptor 7 (TLR7)
|
|
• non-secretion of type I interferons (IFN-alpha/IFN-beta) by plasmacytoid dendritic cells (pDCs) in response to in vivo stimulation by the toll-like receptor 9 (TLR9) ligand, CpG
• reduced secretion of type I interferons (IFN-alpha/IFN-beta) by plasmacytoid dendritic cells in response to in vivo stimulation by resiquimod, a single-stranded (ss) RNA mimetic recognized by toll-like receptor 7 (TLR7)
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf7m1Btlr mutation
(1 available);
any
Irf7 mutation
(23 available)
|
|
|
immune system
|
• reduced secretion of type I interferons (IFNalpha/IFNbeta) by plasmacytoid dendritic cells (pDCs) in response to in vivo stimulation by resiquimod, a ss-RNA mimetic recognized by toll-like receptor 7 (TLR7)
• in contrast to the attenuated response of mice homozygous for this mutation, heterozygous mutant mice exhibit normal secretion of type I interferons by plasmacytoid dendritic cells in response to in vivo stimulation by the toll-like receptor 9 (TLR9) ligand, CpG
|
|
• reduced secretion of type I interferons (IFNalpha/IFNbeta) by plasmacytoid dendritic cells (pDCs) in response to in vivo stimulation by resiquimod, a ss-RNA mimetic recognized by toll-like receptor 7 (TLR7)
• in contrast to the attenuated response of mice homozygous for this mutation, heterozygous mutant mice exhibit normal secretion of type I interferons by plasmacytoid dendritic cells in response to in vivo stimulation by the toll-like receptor 9 (TLR9) ligand, CpG
|